Vicplas International (SGX:569) EPS (Basic): S$-0.01 (TTM As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vicplas International EPS (Basic)?

Vicplas International SGX:569 EPS (Basic) is S$-0.01 as of Jan. 2026. The stock has 5 warning signs investors should review.

Vicplas International's basic earnings per share (Basic EPS) for the six months ended in Jan. 2026 was S$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2026 was S$-0.01.

Vicplas International's EPS (Diluted) for the six months ended in Jan. 2026 was S$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 was S$-0.01.

Vicplas International's EPS without NRI for the six months ended in Jan. 2026 was S$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2026 was -0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Vicplas International's highest 3-Year average EPS without NRI Growth Rate was 39.50% per year. The lowest was -16.40% per year. And the median was 0.00% per year.

Vicplas International  (SGX:569) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Vicplas International EPS (Basic) Related Terms

Vicplas International EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Vicplas International's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vicplas International EPS (Basic) Chart

Vicplas International Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.01 -0.00 -0.01

Vicplas International Semi-Annual Data
Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 -0.01 -0.01

Vicplas International EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Vicplas International's Basic EPS for the fiscal year that ended in Jul. 2025 is calculated as

Basic EPS (A: Jul. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-2.357-0)/511.077
=-0.00

Vicplas International's Basic EPS for the quarter that ended in Jan. 2026 is calculated as

Basic EPS (Q: Jan. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-3.433-0)/511.077
=-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of S$-0.01 mean?
Vicplas International (SGX:569) has a EPS (Basic) of S$-0.01 as of Jan. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Vicplas International and its competitors.
Is Vicplas International's EPS (Basic) too high?
Vicplas International's current EPS (Basic) is S$-0.01.
How does Vicplas International's EPS (Basic) compare to ABT and SYK?
Vicplas International's EPS (Basic) of S$-0.01 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Vicplas International and its competitors. Vicplas International's current EPS (Basic) is S$-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicplas International stock overvalued right now?
Based on GuruFocus' analysis, Vicplas International (SGX:569) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.11, compared to a current price of S$0.08 — trading 30% below its estimated fair value. The current EPS (Basic) is S$-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Vicplas International (SGX:569), the current EPS (Basic) is S$-0.01 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vicplas International Business Description

Address 35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, Mexico, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.